Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Glutamate is an important neurotransmitter present in over 90% of all brain synapses and is a naturally occurring molecule that nerve cells use to send signals to other cells in the central nervous system.
Glutamate is a non-essential amino acid with restricted passage to the brain from the blood. In the CNS, glutamate is synthesised in neurons as part of the glutamate-glutamine cycle.5,6 so it plays an essential role in normal brain functioning and can improve situations related to impaired cognitive,motor and emotional functions and can be used to improve traumatic brain injury patient general health status
The term "brain injury" covers a wide range of conditions and injuries relating to the brain, skull, and scalp. A traumatic brain injury (TBI) usually results when the head or body suffers from a violent blow or jolt that results in swelling, bruising, bleeding, or tearing of the brain tissue which any damage to it has the potential to change the way your body operates.
Now ,(TBI) is considered one of the major causes of disability and deaths ,As It contributes more than 30% Of deaths worldwide . Those who survive a TBI can face effects that last a few days, or the rest of their lives. Effects of TBI can include impaired motor, cognitive and emotional functioning. These issues not only affect individuals but can have lasting effects on families and communities.TBI can also cause some inflammatory mediators to be released in circulation that affect brain and systemic organs such as cortisol,IL6 and TNF etc. A lot of modialities have been introduced to help in decreasing these side effects.
Glutamine,a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells.glutamine has a restricted passage to the brain from blood but it is synthesised in the brain as a part of the glutamate-glutamine cycle.5,6 so it present in over 90% of all brain synapses and is a naturally occurring molecule that nerve cells use to send signals to other cells in the central nervous system,maintaining normal brain function and can improve situations related to impaired cognitive,motor and emotional functions.
Hypothesis of this study; Does glutamine therapy have a positive effect on traumatic brain injury patients ?
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Glutamine group | Active Comparator | 30 patients will recieve .3 mg/kg of glutamine for first 7 days in ICU |
|
| Placcebo group | Placebo Comparator | 30 patients will recieve placcebo for first 7 days in ICU |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Glutamine | Drug | .3 mg/kg of glutamine |
| |
| Placcebo |
| Measure | Description | Time Frame |
|---|---|---|
| The duration of ICU stay | The duration of ICU stay after glutamine adiminstration | First 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Consiousness level by Glagow coma scale | Glasgow coma scale improvement | 30 days |
| The incidence of Convulsions | Convulsions controled by glutamine |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Engy Raafat Youssif, Master student | Contact | 01226016909 | Engiraafat95@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Mohamed Hassan Bakri, Professor | Assiut University | Study Chair |
| Emad Zarief Kamel, Assistant professor | Assiut University | Study Director |
Not provided
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000070642 | Brain Injuries, Traumatic |
| ID | Term |
|---|---|
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005973 | Glutamine |
| ID | Term |
|---|---|
| D024361 | Amino Acids, Basic |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
| D000599 | Amino Acids, Diamino |
Not provided
Not provided
2 groups will recieve glutamine ,the other will be placcebo group
Not provided
Not provided
Double blinded clinical trial Masking for patient,their relatives and outcome assessor
| Other |
Patients will recieve placcebo |
|
| 30 days |
| https://www.google.com/url?sa=t\&source=web\&rct=j\&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133642/\&ved=2ahUKEwj6lYmLpb36AhV0hv0HHXvCBlYQFnoECEIQAQ\&usg=AOvVaw1\_kGwGwx5h2G2svqnAp1SJ | View source |
| Related Info | View source |
| D006259 |
| Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |
| D021542 | Amino Acids, Neutral |